Home LiteratureArticle Details
PMID: 17075052 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Cardiac myosin binding protein C phosphorylation is cardioprotective.

Sadayappan S, Osinska H, Klevitsky R, Lorenz JN, Sargent M, Molkentin JD, Seidman CE, Seidman JG, Robbins J

Abstract

Cardiac myosin binding protein C (cMyBP-C) has three phosphorylatable serines at its N terminus (Ser-273, Ser-282, and Ser-302), and the residues' phosphorylation states may alter thick filament structure and function. To examine the effects of cMyBP-C phosphorylation, we generated transgenic mice with cardiac-specific expression of a cMyBP-C in which the three phosphorylation sites were mutated to aspartic acid, mimicking constitutive phosphorylation (cMyBP-C(AllP+)). The allele was bred into a cMyBP-C null background (cMyBP-C((t/t))) to ensure the absence of endogenous dephosphorylated cMyBP-C. cMyBP-C(AllP+) was incorporated normally into the cardiac sarcomere and restored normal cardiac function in the null background. However, subtle changes in sarcomere ultrastructure, characterized by increased distances between the thick filaments, indicated that phosphomimetic cMyBP-C affects thick-thin filament relationships, and yeast two-hybrid data and pull-down studies both showed that charged residues in these positions effectively prevented interaction with the myosin heavy chain. Confirming the physiological relevance of these data, the cMyBP-C(AllP+:(t/t)) hearts were resistant to ischemia-reperfusion injury. These data demonstrate that cMyBP-C phosphorylation functions in maintaining thick filament spacing and structure and can help protect the myocardium from ischemic injury.

MeSH Terms
Amino Acid Sequence Amino Acid Substitution Animals Binding Sites/genetics Carrier Proteins/chemistry,genetics,metabolism Female Male Mice Mice, Knockout Mice, Transgenic Molecular Sequence Data Mutagenesis, Site-Directed Myocardial Reperfusion Injury/metabolism,pathology,prevention & control Myocardium/metabolism,pathology Myosins/metabolism Phenotype Phosphorylation Recombinant Proteins/chemistry,genetics,metabolism Sarcomeres/metabolism,pathology
Chemicals
Carrier Proteins Recombinant Proteins myosin-binding protein C Myosins
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Sadayappan Sakthivel
Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Osinska Hanna
Klevitsky Raisa
Lorenz John N
Sargent Michelle
Molkentin Jeffrey D
Seidman Christine E
Seidman Jonathan G
Robbins Jeffrey
References (32)
32 references, click to expand
  1. Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice.
    J Clin Invest. 1999 Nov;104(9):1235-44 PMID: 10545522
  2. Activation of myocardial contraction by the N-terminal domains of myosin binding protein-C.
    Circ Res. 2006 May 26;98(10):1290-8 PMID: 16614305
  3. Multiple structures of thick filaments in resting cardiac muscle and their influence on cross-bridge interactions.
    Biophys J. 2001 Aug;81(2):1070-82 PMID: 11463648
  4. Changes in cardiac contractility related to calcium-mediated changes in phosphorylation of myosin-binding protein C.
    Biophys J. 2001 Aug;81(2):1083-92 PMID: 11463649
  5. Role of beta 1- and beta 2-adrenoceptor subtypes in preconditioning against myocardial dysfunction after ischemia and reperfusion.
    J Cardiovasc Pharmacol. 2003 Mar;41(3):396-405 PMID: 12605018
  6. Effect of MyBP-C binding to actin on contractility in heart muscle.
    J Gen Physiol. 2003 Dec;122(6):761-74 PMID: 14638934
  7. Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo.
    J Biol Chem. 2004 Apr 9;279(15):15524-30 PMID: 14749328
  8. Myosin binding protein C: structural abnormalities in familial hypertrophic cardiomyopathy.
    Cell Res. 2004 Apr;14(2):95-110 PMID: 15115610
  9. A new protein of the thick filaments of vertebrate skeletal myofibrils. Extractions, purification and characterization.
    J Mol Biol. 1973 Mar 15;74(4):653-76 PMID: 4269687
  10. The binding of skeletal muscle C-protein to F-actin, and its relation to the interaction of actin with myosin subfragment-1.
    J Mol Biol. 1978 Oct 5;124(4):571-86 PMID: 152359
  11. Myosin isoenzyme changes in several models of rat cardiac hypertrophy.
    Circ Res. 1981 Aug;49(2):525-32 PMID: 6454511
  12. Heart C-protein is transiently expressed during skeletal muscle development in the embryo, but persists in cultured myogenic cells.
    Dev Biol. 1985 Dec;112(2):345-52 PMID: 3908193
  13. The earliest form of C-protein expressed during striated muscle development is immunologically the same as cardiac-type C-protein.
    J Biochem. 1986 Apr;99(4):1037-47 PMID: 3519599
  14. Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts.
    Biochem J. 1988 Feb 1;249(3):709-14 PMID: 2895634
  15. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction?
    EMBO J. 1995 May 1;14(9):1952-60 PMID: 7744002
  16. Specific degradation of troponin T and I by mu-calpain and its modulation by substrate phosphorylation.
    Biochem J. 1995 May 15;308 ( Pt 1):57-61 PMID: 7755588
  17. A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy.
    Eur J Biochem. 1996 Jan 15;235(1-2):317-23 PMID: 8631348
  18. Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle.
    Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8999-9003 PMID: 8799143
  19. The management of hypertrophic cardiomyopathy.
    N Engl J Med. 1997 Mar 13;336(11):775-85 PMID: 9052657
  20. Breakdown and release of myofilament proteins during ischemia and ischemia/reperfusion in rat hearts: identification of degradation products and effects on the pCa-force relation.
    Circ Res. 1998 Feb 9;82(2):261-71 PMID: 9468197
  21. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy.
    J Clin Invest. 1998 Oct 1;102(7):1292-300 PMID: 9769321
  22. Cardiac myosin-binding protein C (MyBP-C): identification of protein kinase A and protein kinase C phosphorylation sites.
    Arch Biochem Biophys. 1998 Oct 15;358(2):313-9 PMID: 9784245
  23. Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C.
    J Mol Biol. 1999 Feb 26;286(3):933-49 PMID: 10024460
  24. cAPK-phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin-S2 in an on-off fashion.
    FEBS Lett. 1999 Jun 25;453(3):254-9 PMID: 10405155
  25. Ischemic preconditioning and the beta-adrenergic signal transduction pathway.
    Circulation. 1999 Aug 31;100(9):958-66 PMID: 10468527
  26. Impact of beta-myosin heavy chain expression on cardiac function during stress.
    J Am Coll Cardiol. 2004 Dec 21;44(12):2390-7 PMID: 15607403
  27. In vivo and in vitro analysis of cardiac troponin I phosphorylation.
    J Biol Chem. 2005 Jan 7;280(1):703-14 PMID: 15507454
  28. Myosin-binding protein C phosphorylation, myofibril structure, and contractile function during low-flow ischemia.
    Circulation. 2005 Feb 22;111(7):906-12 PMID: 15699252
  29. The role of beta-adrenergic receptor signaling in cardioprotection.
    FASEB J. 2005 Jun;19(8):983-5 PMID: 15802488
  30. Cardiac myosin-binding protein-C phosphorylation and cardiac function.
    Circ Res. 2005 Nov 25;97(11):1156-63 PMID: 16224063
  31. Histidine button engineered into cardiac troponin I protects the ischemic and failing heart.
    Nat Med. 2006 Feb;12(2):181-9 PMID: 16429145
  32. Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2.
    Circ Res. 2000 Jan 7-21;86(1):51-8 PMID: 10625305
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2006-11-07
Epub
2006-00-30
Pages
16918-23
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC1636554
Subset
IM
Grants
NHLBI NIH HHS · R01 HL 69799 · United States
NHLBI NIH HHS · HL 52318 · United States
NHLBI NIH HHS · P50 HL052318 · United States
NHLBI NIH HHS · R01 HL056370 · United States
NHLBI NIH HHS · HL 56370 · United States
NHLBI NIH HHS · HL 60546 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com